Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew I Milowsky

Showing results (121-130 of 205) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, et al.
British Journal of Cancer|October 9, 2018
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapyTracy L Rose, David D Chism, Ajjai S Alva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2018
Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell CarcinomaEric Jonasch, Rebecca S Slack, Daniel M Geynisman, et al.
Tomography (Ann Arbor, Mich.)|March 27, 2026
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on <sup>18</sup>F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest CohortMd Zobaer Islam, Timothy G Perk, Amy Weisman, et al.
Prostate Cancer and Prostatic Diseases|January 26, 2021
Body composition, physical function and quality of life in healthy men and across different stages of prostate cancerErik D Hanson, Cameron K Stopforth, Mohamdod Alzer, et al.
Prostate Cancer and Prostatic Diseases|March 20, 2022
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancerErik D Hanson, Mohamdod Alzer, Jackson Carver, et al.
European Urology|August 25, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settingsCora N Sternberg, Joaquim Bellmunt, Guru Sonpavde, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinomaMatthew I Milowsky, Christian Dittrich, Ignacio Durán, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial CancerChristopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
BJU International|April 5, 2013
Phase II study of everolimus in metastatic urothelial cancerMatthew I Milowsky, Gopa Iyer, Ashley M Regazzi, et al.
Pageof 21

Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, et al.
British Journal of Cancer|October 9, 2018
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapyTracy L Rose, David D Chism, Ajjai S Alva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2018
Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell CarcinomaEric Jonasch, Rebecca S Slack, Daniel M Geynisman, et al.
Tomography (Ann Arbor, Mich.)|March 27, 2026
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on <sup>18</sup>F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest CohortMd Zobaer Islam, Timothy G Perk, Amy Weisman, et al.
Prostate Cancer and Prostatic Diseases|January 26, 2021
Body composition, physical function and quality of life in healthy men and across different stages of prostate cancerErik D Hanson, Cameron K Stopforth, Mohamdod Alzer, et al.
Prostate Cancer and Prostatic Diseases|March 20, 2022
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancerErik D Hanson, Mohamdod Alzer, Jackson Carver, et al.
European Urology|August 25, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settingsCora N Sternberg, Joaquim Bellmunt, Guru Sonpavde, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinomaMatthew I Milowsky, Christian Dittrich, Ignacio Durán, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial CancerChristopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
BJU International|April 5, 2013
Phase II study of everolimus in metastatic urothelial cancerMatthew I Milowsky, Gopa Iyer, Ashley M Regazzi, et al.
Pageof 21